Cargando…

Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis

Myo-inositol exerts many cellular functions, which include osmo-protection, membrane functioning, and secondary messaging. Its Na(+)/myo-inositol co-transporter SLC5A3 is expressed in muscle tissue and further accumulates in myositis. In this study we focused on the peculiar subgroup of sporadic inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Paepe, Boel, Merckx, Caroline, Jarošová, Jana, Cannizzaro, Miryam, De Bleecker, Jan L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226596/ https://www.ncbi.nlm.nih.gov/pubmed/32235474 http://dx.doi.org/10.3390/biom10040521

Ejemplares similares

Description of Osmolyte Pathways in Maturing Mdx Mice Reveals Altered Levels of Taurine and Sodium/Myo-Inositol Co-Transporters
por: Merckx, Caroline, et al.
Publicado: (2022)

Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras
por: De Paepe, Boel
Publicado: (2019)

Retrospective Study Shows That Serum Levels of Chemokine CXCL10 and Cytokine GDF15 Support a Diagnosis of Sporadic Inclusion Body Myositis and Immune-Mediated Necrotizing Myopathy
por: De Paepe, Boel, et al.
Publicado: (2023)

Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis
por: Wanschitz, Julia V., et al.
Publicado: (2013)

The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis
por: Gang, Qiang, et al.
Publicado: (2015)

Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis
por: Gang, Qiang, et al.
Publicado: (2016)

Induction of Osmolyte Pathways in Skeletal Muscle Inflammation: Novel Biomarkers for Myositis
por: De Paepe, Boel, et al.
Publicado: (2018)

Immune‐Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA–DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum
por: Rothwell, Simon, et al.
Publicado: (2017)

Proteomic study of sporadic inclusion body myositis
por: Li, Ke, et al.
Publicado: (2014)

Ongoing Developments in Sporadic Inclusion Body Myositis
por: Machado, Pedro M., et al.
Publicado: (2014)

Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken
por: Benveniste, Olivier, et al.
Publicado: (2015)

An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis
por: De Paepe, Boel, et al.
Publicado: (2022)

Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis
por: Lucchini, Matteo, et al.
Publicado: (2023)

Sporadic inclusion body myositis: the genetic contributions to the pathogenesis
por: Gang, Qiang, et al.
Publicado: (2014)

Mitochondrial and inflammatory changes in sporadic inclusion body myositis
por: Rygiel, Karolina A., et al.
Publicado: (2015)

Emerging therapeutic options for sporadic inclusion body myositis
por: Alfano, Lindsay N, et al.
Publicado: (2015)

CYLD dysregulation in pathogenesis of sporadic inclusion body myositis
por: Yamashita, Satoshi, et al.
Publicado: (2019)

COVID-19-Induced Sporadic Inclusion Body Myositis
por: Dalal, Fazal, et al.
Publicado: (2022)

SLC5A3-Dependent Myo-inositol Auxotrophy in Acute Myeloid Leukemia
por: Wei, Yiliang, et al.
Publicado: (2022)

Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women
por: Montanino Oliva, Mario, et al.
Publicado: (2018)

Evaluation of expression and function of the H(+)/myo-inositol transporter HMIT
por: Di Daniel, Elena, et al.
Publicado: (2009)

Balloon Dilation in Sporadic Inclusion Body Myositis Patients with Dysphagia
por: Murata, Ken-ya, et al.
Publicado: (2013)

Multicenter questionnaire survey for sporadic inclusion body myositis in Japan
por: Suzuki, Naoki, et al.
Publicado: (2016)

Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges
por: Mohannak, Nika, et al.
Publicado: (2019)

Metabolome and transcriptome analysis on muscle of sporadic inclusion body myositis
por: Murakami, Ayuka, et al.
Publicado: (2022)

The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth
por: Cui, Zihan, et al.
Publicado: (2022)

Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate
por: Bizzarri, Mariano, et al.
Publicado: (2016)

2-Benzyl-myo-inositol monohydrate
por: Fröhlich, Richard F. G., et al.
Publicado: (2009)

The heart in sporadic inclusion body myositis: a study in 51 patients
por: Cox, Fieke M., et al.
Publicado: (2009)

Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis
por: Dubourg, O., et al.
Publicado: (2011)

The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan
por: Suzuki, Naoki, et al.
Publicado: (2019)

Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis
por: Vogt, Sinja, et al.
Publicado: (2023)

Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse
por: Merckx, Caroline, et al.
Publicado: (2022)

The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy
por: Merckx, Caroline, et al.
Publicado: (2022)

Comparative Genomics of Pneumocystis Species Suggests the Absence of Genes for myo-Inositol Synthesis and Reliance on Inositol Transport and Metabolism
por: Porollo, Aleksey, et al.
Publicado: (2014)

Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition
por: Tortolini, Cristina, et al.
Publicado: (2023)

Myo-inositol oxygenase is important for the removal of excess myo-inositol from syncytia induced by Heterodera schachtii in Arabidopsis roots
por: Siddique, Shahid, et al.
Publicado: (2014)

Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy()
por: Cortese, Andrea, et al.
Publicado: (2014)

Increased plasma amyloid-β(42) protein in sporadic inclusion body myositis
por: Abdo, Wilson F., et al.
Publicado: (2009)

Vacuolar myopathy in a dog resembling human sporadic inclusion body myositis
por: King, Jason, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2mdjvahi0kepu5dpjva2a8vam2